Viagra Tablet, Film Coated
Product Images NDC 0069-4200

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Viagra (NDC 0069-4200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Viagra 01)

Chemical structure of sildenafil citrate, the active ingredient in Viagra tablets. The diagram shows the molecular formula with distinct chemical groups and bonds representing the compound's arrangement.*

FDA Label Image

Figure 1 (Viagra 02)

A line graph comparing systolic blood pressure (mmHg) over 24 hours between sildenafil 100 mg and placebo groups. The x-axis shows time post dose in hours, and the y-axis shows systolic blood pressure changes. Data points indicate blood pressure measurements before dose and up to 24 hours after dosing for both treatments.*

FDA Label Image

Figure 2 (Viagra 03)

A line graph depicting the change in systolic blood pressure (SBP) over time in hours after dosing for three groups: Doxazosin + Placebo and Doxazosin + Sildenafil 25 mg. The x-axis represents time post-dose in hours, and the y-axis shows the change in SBP in mmHg. Data points for each treatment group are plotted and connected with lines.*

FDA Label Image

Figure 3 (Viagra 04)

A line graph showing change in SBP (systolic blood pressure) in mmHg plotted over time postdose (hours). It compares two treatments: Doxazosin plus Placebo (blue line) and Doxazosin plus Sildenafil 50 mg (black line), charting their SBP changes over an 8-hour period.*

FDA Label Image

Figure 4 (Viagra 05)

A line graph showing changes in mmHg over time (hours) after dosing with doxazosin plus sildenafil 100 mg compared to doxazosin plus placebo. The x-axis measures time after dosing from 0 to 8 hours, and the y-axis measures mmHg from -50 to 40. Data points for both treatments are connected by lines for comparison.*

FDA Label Image

Figure 5 (Viagra 06)

A pharmacokinetic curve displaying plasma concentration (ng/mL) over time (hours) following a dose of a commercial tablet formulation. The graph shows an initial rapid increase in concentration, peaking around 1 hour post-dose, followed by a gradual decline up to 24 hours.*

FDA Label Image

Figure 6 (Viagra 07)

A bar graph titled 'Effect of VIAGRA on Maintenance of Erection by Baseline Score.' The x-axis represents baseline scores from 0 to 5, and the y-axis shows the percentage of patients at the endpoint, ranging from 0% to 80%. Multiple bars per baseline score indicate different categories labeled 0 through 5 in the legend. The chart illustrates the distribution of patient responses by baseline score.*

FDA Label Image

Figure 6 (Viagra 08)

A bar chart titled 'Effect of Placebo on Maintenance of Erection by Baseline Score.' The x-axis represents baseline scores from 0 to 5, and the y-axis represents the percentage of patients at the endpoint, ranging from 0 to 80%. Multiple bars for each baseline score indicate different score categories (0 to 5) showing the distribution of patients under placebo treatment regarding erection maintenance.*

FDA Label Image

Figure 7 (Viagra 09)

Bar chart showing the percentage of patients reporting improvement across treatment groups for Viagra tablets, film coated, at doses of 25 mg, 50 mg, and 100 mg compared to placebo. The chart illustrates increasing patient improvement percentages with higher Viagra doses from 24% for placebo to 82% for the 100 mg dose.*

FDA Label Image

Logo (Viagra 10)

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Viagra 25 mg film-coated tablets label showing the product name, sildenafil citrate as the active ingredient, and dosage strength. It indicates 30 tablets per package, prescription use only, and is distributed by Pfizer Labs, a division of Pfizer Inc. Storage instructions and a barcode are also visible on the label.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Label for Viagra (sildenafil citrate) tablets, 50 mg strength, film-coated oral tablets. The label includes the Pfizer logo, NDC 0069-4210-30, indicates a package of 30 tablets, and states 'Rx only.' Storage instructions and manufacturer information show Pfizer Labs, made in Ireland.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Viagra 100 mg film-coated tablets packaging label showing the active ingredient sildenafil citrate. The label indicates a quantity of 30 tablets and prescription-only status. It features Pfizer branding and storage information at 25°C (77°F) with permitted excursions. The product is distributed by Pfizer Labs Division, Pfizer Inc, and made in Ireland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.